-
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
19 Aug 2025 12:55 GMT
… ; August 19, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA … ;Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics … of Principal Investigator Prof. Yoseph Caraco, demonstrated a favorable safety and …
-
Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
05 Aug 2025 12:15 GMT
… , a proprietary MEAI-based oral drug candidate, for the treatment of … Medical Center will be led by Prof. Joseph Caraco, Director of Clinical Pharmacology … Unit in the Department of Medicine. IRB …
-
Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman
13 Jun 2025 16:19 GMT
… succession planning process at Sun Pharma, underscoring the organisation’s … pursue his interests outside Sun Pharma, the statement says. Further, … , Caraco Pharmaceutical Laboratories facilitated entry into US2010: Launched first generic version cancer drug, …
-
Dilip Shanghvi has built Sun Pharma by making bold bets. And he's not done yet
30 Apr 2025 07:16 GMT
… about a new weight loss medicine that is showing promising … its first, acquiring US-based Caraco Pharmaceutical Laboratories to mark its entry into … areas beyond neuropsychiatry. “Sun Pharma started by launching neuropsychiatric drugs. Later, we entered …
-
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (Fed. Cir. 2025)
24 Mar 2025 19:56 GMT
… Court's opinion in Caraco Pharm. Lab'ys … is used (wherein in Caraco the Court interpreted the … a generic drugmaker could raise in ANDA litigation). In Caraco, the … Pharmaceutical Industries Ltd.; Fresenius Kabi USA, LLC; Dr. Reddy's Laboratories …
-
From A Modest Shed To Market Dominance: Dilip Shanghvi’s Rise As India’s Pharma Trailblazer
25 Feb 2025 08:14 GMT
… foothold abroad. Sun Pharma acquired Caraco Pharma in the United … it respiratory medications from NATCO Pharma or ophthalmology … push for generic drug approvals, Shanghvi orchestrated … Laboratories. This deal, valued at ₹2,000 crore, instantly made Sun Pharma …
-
CARACO Data Add to Evidence Supporting Omission of Lymphadenectomy in Advanced Ovarian Cancer Without Suspicious Lymph Nodes
27 Aug 2024 22:51 GMT
… lymphadenectomy. However, the CARACO trial was for patients … New England Journal of Medicine. The LION trial [data … after primary surgery. The CARACO trial brings additional information … after neoadjuvant chemotherapy: The CARACO phase III randomized trial. …
-
Sun Pharmaceuticals Industries Ltd ₹1468.1 24.65 (1.68%) 1397857
29 May 2024 07:42 GMT
… of US firm Caraco Pharmaceutical Laboratories. In 1999, Sun Pharma acquired Milmet Labs … Sun Pharma acquired Pradeep Drug Company. In 2004, Sun Pharma acquired Phlox Pharma (India … Sun Pharma has more than 40 manufacturing facilities and provides medicines to …
-
Nasus Pharma Announces Positive Clinical Results of Recent Phase 2 Study With FMXIN002 Intranasal Epinephrine
06 Dec 2023 03:29 GMT
…
Prof. Yoseph Caraco, the principal investigator at Hadassah medical center added:
… ensure immediate response the pharmacokinetics /pharmacodynamics of epinephrine rescue are … available intramuscular route of drug administration and other solution- …
-
Who is Indian billionaire Dilip Sanghvi, the man behind Sun Pharma? Know about his Rs 15.65 lakh crore net worth
16 Dec 2023 21:42 GMT
… , a pharmaceutical distributor in Kolkata, to establish a company producing its medicines … moves include acquiring Detroit-based Caraco Pharma in 1997, Israel’s Taro … rival Ranbaxy Laboratories in 2014. In March 2023, Sun Pharma further solidified …